Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Obtaining health-state utility values (HSUVs) aids in making scientific decisions in patient health management, especially for rare disease patients. However, there is currently no research specifically measuring the HSUVs of Chinese hemophilia B patients. Therefore, this study aims to assess the HSUVs of hemophilia B patients in China and explore its potential influencing factors.
Methods: The sociodemographic characteristics of patients were obtained from the Beijing Hemophilia Home Care Center (BHHCC) database. And the HSUVs were further obtained by reaching hemophilia B patients through an application of BHHCC and the Chinese version of the EQ-5D-5L. The beta regression model was used to explore the potential influencing factors of the HSUVs of patients.
Results: A total of 167 male patients (hemophilia B is an X-chromosome recessive disorder and female patients are rare) were included in the study. The mean age, HSUV and EQ-VAS were 20.01 ± 15.83, 0.755 ± 0.291 and 71.7 ± 22.7, respectively. The ceiling effects was 29.24%, and patients were more likely to experience problems in Pain/discomfort (57.49%). Compared to self-completion, proxy may overestimate HSUVs of patients. Pain (p < 0.000), disability (p < 0.000), complications (p < 0.001), inhibitors (p < 0.01), drug usage (p < 0.001), and bleeds (p < 0.000) were significantly associated with HSUVs in Chinese hemophilia B patients.
Conclusions: This study first assessed the HSUVs of Chinese hemophilia B patients, which provides support for further economic studies. Potential factors that affect the HSUVs of Chinese hemophilia B patients were also explored, which can provide a reference for developing health management measures. However, to enact more comprehensive and reliable disease management decisions, the effects of self-completion and proxy on the HSUVs of hemophilia B patients in China need to be further explored as well as the effects of specific factors.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12333264 | PMC |
| http://dx.doi.org/10.1186/s13023-025-03894-y | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Promising Frontier in Cancer Therapy - Combining Endothelial Colony Forming Cells, Nanotechnology, and Hyperthermia for Precision Oncology.
Stem Cell Rev Rep
September 2025
Paris Cité University, INSERM UMR-S 970, Paris Cardiovascular Research Centre, Paris, France.
Endothelial Colony-Forming Cells (ECFCs) are recognized as key vasculogenic progenitors in humans and serve as valuable liquid biopsies for diagnosing and studying vascular disorders. In a groundbreaking study, Anceschi et al. present a novel, integrative strategy that combines ECFCs loaded with gold nanorods (AuNRs) to enhance tumor radiosensitization through localized hyperthermia.
View Article and Find Full Text PDFAdvancing Understanding of Ligneous Conjunctivitis: Bridging Pathogenesis, Diagnosis, and Therapy.
Cornea
September 2025
Cornea Department, Ophthalmic Consultants of Long Island, Rockville Center, NY.
Purpose: This review and case report address ligneous conjunctivitis (LC), a rare ocular condition caused by plasminogen deficiency type 1 (PLGD-1), which manifests as wood-like fibrin-rich membranes on the palpebral conjunctiva. The goal is to provide ophthalmologists-often the first physicians to encounter the condition-with a robust understanding of its systemic manifestations and to highlight current therapeutic strategies, with particular emphasis on the administration of intravenous plasminogen concentrate.
Methods: We present a clinical LC case alongside a narrative review of published cases, etiology, and treatment approaches.
Recent Advances in Gene Therapy for Hemophilia.
Clin Appl Thromb Hemost
September 2025
Pediatric Hematology Laboratory, Division of Hematology/Oncology, Department of Pediatrics, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, Guangdong, China.
Hemophilia, an X-linked monogenic disorder, arises from mutations in the or genes, which encode clotting factor VIII (FVIII) or clotting factor IX (FIX), respectively. As a prominent hereditary coagulation disorder, hemophilia is clinically manifested by spontaneous hemorrhagic episodes. Severe cases may progress to complications such as stroke and arthropathy, significantly compromising patients' quality of life.
View Article and Find Full Text PDFClinical features and surgical treatment of haemophilic pseudotumors: A single center experience over a 20-year period.
J Chin Med Assoc
September 2025
Division of Joint Reconstruction, Department of Orthopedics and Traumatology, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
Background: Haemophilia pseudotumor (HPT) is an uncommon but severe complication in patients with haemophilia (PWH). Given the rarity, case series were scarce and largely confined to case report in the literature. Consequently, the aim of this study is to present surgical results of HPT over a 20-year period from a single institute.
View Article and Find Full Text PDFComparative Effectiveness of Valoctocogene Roxaparvovec and Efanesoctocog Alfa in the Treatment of Severe Hemophilia A: A Matching-Adjusted Indirect Comparison of Bleeding Frequency.
Adv Ther
September 2025
Petauri Evidence, Nottingham, UK.
Introduction: Hemophilia A, an X-linked recessive bleeding disorder, is characterized by reduced factor VIII (FVIII) activity. Hemophilia A can significantly impact a person's quality of life because of the risk of spontaneous bleeding. Treatment for hemophilia A aims to prevent bleeding from occurring.
View Article and Find Full Text PDF